The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Chronic Inflammation in Cancer Development
Open accessAbstract
Chronic inflammatory mediators exert pleiotropic effects in the development of cancer. On the one hand, inflammation favors carcinogenesis, malignant transformation, tumor growth, invasion, and metastatic spread; on the other hand inflammation can stimulate immune effector mechanisms that might limit tumor growth. The link between cancer and inflammation depends on intrinsic and extrinsic pathways. Both pathways result in the activation of transcription factors such as NF-κB, STAT-3, and HIF-1 and in accumulation of tumorigenic factors in tumor and microenvironment. STAT-3 and NF-κB interact at multiple levels and thereby boost tumor-associated inflammation which can suppress anti-tumor immune responses. These factors also promote tumor growth, progression, and metastatic spread. IL-1, IL-6, TNF, and PGHS-2 are key mediators of an inflammatory milieu by modulating the expression of tumor-promoting factors. In this review we concentrate on the crucial role of pro-inflammatory mediators in inflammation-driven carcinogenesis and outline molecular mechanisms of IL-1 signaling in tumors. In addition, we elucidate the dual roles of stress proteins as danger signals in the development of anti-cancer immunity and anti-apoptotic functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Lindquist, S., & Craig, E. A. (1988) · Annual Review of Genetics · doi:10.1146/annurev.ge.22.120188.003215 · Cited by 5,284
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“…comprise to members of the Toll-like receptor (TLR) family, nucleotide-binding oligomerization domain-like (NODlike) receptors (NLR), C-type lectin receptors (CLR), triggering receptors on myeloid cells (TREM), and retinoic acid inducible gene-I-like receptors (RLR; Kawai and Akira, 2011).”
BackgroundMolecular chaperones in cellular protein folding
Hartl, F. U. (1996) · Nature · doi:10.1038/381571a0 · Cited by 3,568
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 3×
“EMT refers to the loss of carcinoma epithelial phenotype and the acquisition of mesenchymal features (Zeisberg and Neilson, 2009).”
BackgroundA homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 3×
“These findings indicate that pro-inflammatory activity of TNF functions as a pivotal mediator in tumorigenesis (Lin and Karin, 2007).”
BackgroundGhiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Asea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Heat shock factors: integrators of cell stress, development and lifespan
Åkerfelt, M., Morimoto, R. I., & Sistonen, L. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2938 · Cited by 1,455
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
TRAF6 is a signal transducer for interleukin-1
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,303
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Shaping the nuclear action of NF-κB
Chen, L.-F., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,221
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 Signaling
Muzio, M., Ni, J., Feng, P., & Dixit, V. M. (1997) · Science · doi:10.1126/science.278.5343.1612 · Cited by 1,170
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.c7086 · Cited by 1,166
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S., & Cao, Z. (1997) · Immunity · doi:10.1016/s1074-7613(00)80402-1 · Cited by 1,117
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Roles of the heat shock transcription factors in regulation of the heat shock response and beyond
PIRKKALA, L., NYKÄNEN, P., & SISTONEN, L. (2001) · The FASEB Journal · doi:10.1096/fj00-0294rev · Cited by 1,009
Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
Hofbauer, L. C. (2004) · JAMA · doi:10.1001/jama.292.4.490 · Cited by 988
The biology of erbB-2/nue/HER-2 and its role in cancer
Hynes, N. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 971
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Matzinger, P. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0143 · Cited by 748
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706
Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., & Multhoff, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3804 · Cited by 695
Self-citationPersistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683
The multifaceted roles of nitric oxide in cancer
Wink, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.711 · Cited by 682 · cited 2×
“, 2002), and gastrointestinal carcinomas (Wink et al., 1998; Jaiswal et al., 2001).”
BackgroundRose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Interleukin l and T Cell Activation
Mizel, S. B. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb00411.x · Cited by 613
Wilson, K. T., Fu, S., Ramanujam, K. S., & Meltzer, S. J. (1998) · PubMed · Cited by 591
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Shin, B. K., Wang, H., Yim, A. M., Le Naour, F., Brichory, F., Jang, J. H., Zhao, R., Puravs, E., Tra, J., Michael, C. W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210455200 · Cited by 520
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 517
Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations
Lambert, J. D., Hong, J., Yang, G.-Y., Liao, J., & Yang, C. S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.284s · Cited by 499
Virchow, R. (1978) · Springer eBooks · doi:10.1007/978-3-642-66491-5 · Cited by 482
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Lewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 443
Multhoff, G., Botzler, C., Wiesnet, M., Müller, E., Meier, T., Wilmanns, W., & Issels, R. D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610222 · Cited by 432
Self-citationTumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family
Martin, M. U., & Wesche, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00320-8 · Cited by 426
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Molina, M. A., Sitjà, M., Lemoine, M. G., Frazier, M. L., & Sinicrope, F. A. (1999) · PubMed · Cited by 404
Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors
Grösch, S., Maier, T. J., Schiffmann, S., & Geisslinger, G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj206 · Cited by 400
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells
Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart, J., & Issels, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4341 · Cited by 387
Self-citationImmune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Chien, Y., Kim, S., Bumeister, R., Loo, Y.-M., Kwon, S. W., Johnson, C. L., Balakireva, M. G., Romeo, Y., Kopelovich, L., Gale, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.034 · Cited by 368
Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., Arber, N., Levin, B., Meinert, C. L., Martin, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.764530 · Cited by 367
Identification, classification, and expression of RAGE gene splice variants
Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-9909com · Cited by 360
Serum interleukin‐6 levels reflect the disease status of colorectal cancer
Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 353
Shimizu, M., Deguchi, A., Lim, J. T. E., Moriwaki, H., Kopelovich, L., & Weinstein, I. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2014 · Cited by 347
Mori, T., Miyamoto, T., Yoshida, H., Asakawa, M., Kawasumi, M., Kobayashi, T., Morioka, H., Chiba, K., Toyama, Y., & Yoshimura, A. (2011) · International Immunology · doi:10.1093/intimm/dxr077 · Cited by 328
Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling
Born, T. L., Thomassen, E., Bird, T. A., & Sims, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29445 · Cited by 328
Wesche, H., Korherr, C., Kracht, M., Falk, W., Resch, K., & Martin, M. U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7727 · Cited by 326
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Lachmann, H. J., Lowe, P., Felix, S. D., Rordorf, C., Leslie, K., Madhoo, S., Wittkowski, H., Bek, S., Hartmann, N., Bosset, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082481 · Cited by 312
Tumor necrosis factor, cancer and anticancer therapy
MOCELLIN, S., ROSSI, C., PILATI, P., & NITTI, D. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.001 · Cited by 311
Okamoto, M., Liu, W., Luo, Y., Tanaka, A., Cai, X., Norris, D. A., Dinarello, C. A., & Fujita, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064907 · Cited by 293
Molecular chaperones in cellular protein folding
Ulrich Hartl, F., & Martin, J. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80014-r · Cited by 288
Ambs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., & Harris, C. C. (1998) · Nature Medicine · doi:10.1038/3957 · Cited by 287
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis
Jaiswal, M., LaRusso, N. F., & Gores, G. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g626 · Cited by 278
Why not treat human cancer with interleukin-1 blockade?
Dinarello, C. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9229-0 · Cited by 277
Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis
Peters, M., Müller, A. M., & Rose-John, S. (1998) · Blood · doi:10.1182/blood.v92.10.3495 · Cited by 276
Kishimoto, K., Matsumoto, K., & Ninomiya-Tsuji, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7359 · Cited by 271
Cahill, C. M., & Rogers, J. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707692200 · Cited by 252
Kulp, S. K., Yang, Y.-T., Hung, C.-C., Chen, K.-F., Lai, J.-P., Tseng, P.-H., Fowble, J. W., Ward, P. J., & Chen, C.-S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2396 · Cited by 252
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Wei, D., Wang, L., He, Y., Xiong, H. Q., Abbruzzese, J. L., & Xie, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1945 · Cited by 246
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Osteoprotegerin and RANK ligand expression in prostate cancer.
Brown, J. M., Corey, E., Lee, Z. D., True, L. D., Yun, T. J., Tondravi, M., & Vessella, R. L. (2001) · Urology · doi:10.1016/s0090-4295(00)01122-5 · Cited by 234
Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling
Reddy, S. A. G., Huang, J. H., & Liao, W. S.-L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29167 · Cited by 230
Chen, G., Sircar, K., Aprikian, A., Potti, A., Goltzman, D., & Rabbani, S. A. (2006) · Cancer · doi:10.1002/cncr.21978 · Cited by 226
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Multhoff, G., Mizzen, L., Winchester, C. C., Milner, C. M., Wenk, S., Eissner, G., Kampinga, H. H., Laumbacher, B., & Johnson, J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00104-6 · Cited by 223
Self-citationSiddiqui, I. A., Malik, A., Adhami, V. M., Asim, M., Hafeez, B. B., Sarfaraz, S., & Mukhtar, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210840 · Cited by 223
Intracellular signalling: PDK1 – a kinase at the hub of things
Belham, C., Wu, S., & Avruch, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80058-x · Cited by 222
Structure, function and regulation of the Toll/IL‐1 receptor adaptor proteins
Watters, T. M., Kenny, E. F., & O'Neill, L. A. J. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100095 · Cited by 216
Weaver, C. T., Hawrylowicz, C. M., & Unanue, E. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8181 · Cited by 214
Apte, R. N., Krelin, Y., Song, X., Dotan, S., Recih, E., Elkabets, M., Carmi, Y., Dvorkin, T., White, R. M., Gayvoronsky, L., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.010 · Cited by 211
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
Yoshimatsu, K., Golijanin, D., Paty, P. B., Soslow, R. A., Jakobsson, P. ‐., DeLellis, R. A., Subbaramaiah, K., & Dannenberg, A. J. (2001) · PubMed · Cited by 211
Keating, S. E., Maloney, G. M., Moran, E. M., & Bowie, A. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705266200 · Cited by 210
A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity
Multhoff, G., Pfister, K., Gehrmann, M., Hantschel, M., Gross, C., Hafner, M., & Hiddemann, W. (2001) · Cell Stress & Chaperones · doi:10.1379/1466-1268(2001)006<0337:amhpsn>2.0.co;2 · Cited by 209
Self-citationExpression of both TNF-α receptor subtypes is essential for optimal skin tumour development
Arnott, C. H., Scott, K. A., Moore, R. J., Robinson, S. C., Thompson, R. G., & Balkwill, F. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207317 · Cited by 208
Adhami, V. M., Malik, A., Zaman, N., Sarfaraz, S., Siddiqui, I. A., Syed, D. N., Afaq, F., Pasha, F. S., Saleem, M., & Mukhtar, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2269 · Cited by 205
Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody
Stangl, S., Gehrmann, M., Riegger, J., Kuhs, K., Riederer, I., Sievert, W., Hube, K., Mocikat, R., Dressel, R., Kremmer, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016065108 · Cited by 202
Self-citationNew insights into the mechanism of heat shock response activation
Shamovsky, I., & Nudler, E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7458-y · Cited by 200
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 200
Nitrative DNA damage in inflammation and its possible role in carcinogenesis
Sawa, T., & Ohshima, H. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.06.005 · Cited by 198
Interaction of Heat Shock Protein 70 Peptide with NK Cells Involves the NK Receptor CD94
Gross, C., Hansch, D., Gastpar, R., & Multhoff, G. (2003) · Biological Chemistry · doi:10.1515/bc.2003.030 · Cited by 194
Self-citationTargeting apoptosis pathways by Celecoxib in cancer
Jendrossek, V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2011.01.012 · Cited by 194
Gross, C., Koelch, W., DeMaio, A., Arispe, N., & Multhoff, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302644200 · Cited by 193
Self-citationNew cancer treatment strategy using combination of green tea catechins and anticancer drugs
Suganuma, M., Saha, A., & Fujiki, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01805.x · Cited by 185
Tumor-Specific Hsp70 Plasma Membrane Localization Is Enabled by the Glycosphingolipid Gb3
Gehrmann, M., Liebisch, G., Schmitz, G., Anderson, R., Steinem, C., De Maio, A., Pockley, G., & Multhoff, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001925 · Cited by 182
Self-citationInducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.
Yoshimatsu, K., Altorki, N. K., Golijanin, D., Zhang, F., Jakobsson, P. ‐., Dannenberg, A. J., & Subbaramaiah, K. (2001) · PubMed · Cited by 182
What the Myddosome structure tells us about the initiation of innate immunity
Gay, N. J., Gangloff, M., & O’Neill, L. A. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.005 · Cited by 173
IMPLICATION OF TOLL-LIKE RECEPTOR AND TUMOR NECROSIS FACTOR α SIGNALING IN SEPTIC SHOCK
Lin, W., & Yeh, W. (2005) · Shock · doi:10.1097/01.shk.0000180074.69143.77 · Cited by 170
Maier, T. J., Schilling, K., Schmidt, R., Geisslinger, G., & Grösch, S. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.014 · Cited by 165
IL-1β Breaks Tolerance through Expansion of CD25+ Effector T Cells
O’Sullivan, B. J., Thomas, H. E., Pai, S., Santamaria, P., Iwakura, Y., Steptoe, R. J., Kay, T. W. H., & Thomas, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7278 · Cited by 164
Shinriki, S., Jono, H., Ota, K., Ueda, M., Kudo, M., Ota, T., Oike, Y., Endo, M., Ibusuki, M., Hiraki, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0287 · Cited by 163
Triantafilou, M., & Triantafilou, K. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320636 · Cited by 161
HSP70 peptide-bearing and peptide-negative preparations act as chaperokines
Asea, A. A. A., Kabingu, E., Stevenson, M. A., & Calderwood, S. K. (2000) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2000)005<0425:hpbapn>2.0.co;2 · Cited by 158
JOHNSON, A. J., Hsu, A., Lin, H.-P., Song, X., & Chen, C. (2002) · Biochemical Journal · doi:10.1042/bj20020279 · Cited by 155
Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB
Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Bräutigam, L., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0716fje · Cited by 153
Pidgeon, G. P., Harmey, J. H., Kay, E., Costa, M. D., Redmond, H. P., & Bouchier‐Hayes, D. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6694369 · Cited by 145
Weichert, W., Boehm, M., Gekeler, V., Bahra, M., Langrehr, J. M., Neuhaus, P., Denkert, C., Imre, G., Weller, C., Hofmann, H.-P., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603878 · Cited by 143
Corrupt policemen: inflammatory cells promote tumor angiogenesis
Zumsteg, A., & Christofori, G. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831bed7e · Cited by 142
Natural Killer Cells and Tumor Therapy
Whiteside, T. L., Vujanović, N. L., & Herberman, R. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_13 · Cited by 141
Gastpar, R., Gross, C., Rossbacher, L., Ellwart, J., Riegger, J., & Multhoff, G. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.2.972 · Cited by 140
Self-citationThe IL-1 receptor and Rho directly associate to drive cell activation in inflammation
Singh, R., Wang, B., Shirvaikar, A., Khan, S., Kamat, S., Schelling, J. R., Konieczkowski, M., & Sedor, J. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5754 · Cited by 139
Multhoff, G., Botzler, C., Wiesnet, M., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1374.bloodjournal8641374 · Cited by 138
Self-citationKawata, M., Koinuma, D., Ogami, T., Umezawa, K., Iwata, C., Watabe, T., & Miyazono, K. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr136 · Cited by 136
Wang, S., Liu, Q., Zhang, Y., Liu, K., Yu, P., Liu, K., Luan, J., Duan, H., Lu, Z., Wang, F., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-81 · Cited by 136
Smolen, J. S., Ávila, J. C. M., & Aletaha, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200395 · Cited by 135
Wheeler, D. S., Chase, M. A., Senft, A. P., Poynter, S. E., Wong, H. R., & Page, K. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-31 · Cited by 134
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
Cozen, W., Gill, P. S., Ingles, S. A., Masood, R., nez-Maza, O. M. I., Cockburn, M., Gauderman, W. J., Pike, M. C., Bernstein, L., Nathwani, B. N., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2860 · Cited by 131
Kumar, A., Xu, J., Brady, S. W., Gao, H., Yu, D., Reuben, J. M., & Mehta, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013390 · Cited by 130
Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the PI 3K Pathway
Sandau, K. B., Faus, H., & Brüne, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3789 · Cited by 130
Cerella, C., Sobolewski, C., Dicato, M., & Diederich, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.050 · Cited by 129 · cited 1×
“…to overcome the limitations associated with the toxicity of PGHS-2 inhibitors is to combine chemical PGHS2 inhibitors at low doses with naturally occurring compounds such as the catechin EGCG which is a promising chemopreventive agent derived from green tea (summarized by Cerella et al., 2010).”
BackgroundRole of inflammation in pancreatic carcinogenesis and the implications for future therapy
Garcea, G., Dennison, A. R., Steward, W. P., & Berry, D. P. (2005) · Pancreatology · doi:10.1159/000087493 · Cited by 128
Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate
Chen, L., & Zhang, H. (2007) · Molecules · doi:10.3390/12050946 · Cited by 127
Groß, C. C., Schmidt‐Wolf, I. G. H., Nagaraj, S., Gastpar, R., Ellwart, J. W., Kunz‐Schughart, L. A., & Multhoff, G. (2003) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2003)008<0348:hspria>2.0.co;2 · Cited by 124
Self-citationInterleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women
Hefler, L., Grimm, C., Lantzsch, T., Lampe, D., Leodolter, S., Koelbl, H., Heinze, G., Reinthaller, A., Castillo‐Tong, D. C., Tempfer, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0001 · Cited by 119
Muthuswamy, R., Mueller-Berghaus, J., Haberkorn, U., Reinhart, T. A., Schadendorf, D., & Kaliński, P. (2010) · Blood · doi:10.1182/blood-2009-12-258038 · Cited by 117
Khaleque, A., Bharti, A. K., Sawyer, D. B., Gong, J., Benjamin, I. J., Stevenson, M. A., & Calderwood, S. K. (2005) · Oncogene · doi:10.1038/sj.onc.1208798 · Cited by 115
Chase, M. A., Wheeler, D. S., Lierl, K. M., Hughes, V. S., Wong, H. R., & Page, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6318 · Cited by 111
Human osteosarcoma cells express functional receptor activator of nuclear factor‐kappa B
Mori, K., Goff, B. L., Berreur, M., Riet, A. V., Moreau, A., Blanchard, F., Chevalier, C., Guisle, I., Leger, J. J., Guicheux, J., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2140 · Cited by 108
Patient survival by Hsp70 membrane phenotype
Pfister, K., Radons, J., Busch, R. M., Tidball, J. G., Pfeifer, M., Freitag, L., Feldmann, H., Milani, V., Issels, R. D., & Multhoff, G. (2007) · Cancer · doi:10.1002/cncr.22864 · Cited by 107
Self-citationMurshid, A., Gong, J., Stevenson, M. A., & Calderwood, S. K. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.124 · Cited by 106
Kai, H., Kitadai, Y., Kodama, M., Cho, S., Kuroda, T., Ito, M., Tanaka, S., Ohmoto, Y., & Chayama, K. (2005) · PubMed · Cited by 106
Yamashita, M., Kurokawa, K., Sato, Y., Yamagata, A., Mimura, H., Yoshikawa, A., Sato, K., Nakano, A., & Fukai, S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1722 · Cited by 103
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma, S. H., Lipponen, P., & Kosma, V. M. (2001) · PubMed · Cited by 103
Yip-Schneider, M., Sweeney, C. J., Jung, S., Crowell, P. L., & Marshall, M. S. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29465-9 · Cited by 101
Fahy, B. N., Schlieman, M. G., Virudachalam, S., & Bold, R. J. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.12.005 · Cited by 100
Ladetto, M., Vallet, S., Trojan, A., Dell'Aquila, M., Monitillo, L., Rosato, R., Santo, L., Drandi, D., Bertola, A., Falco, P., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4201 · Cited by 91
Molecular targeting therapy for pancreatic cancer
Xiong, H. Q. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0890-2 · Cited by 89
Heat shock proteins in breast cancer progression–A suitable case for treatment?
Calderwood, S. K. (2010) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.490254 · Cited by 88
Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between
Jura, N., Archer, H., & Bar‐Sagi, D. (2005) · Cell Research · doi:10.1038/sj.cr.7290269 · Cited by 86
Jefferies, C. A., & O'Neill, L. A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3114 · Cited by 85
Mori, K., Berreur, M., Blanchard, F., Chevalier, C., Guisle, I., Masson, M., Rédiní, F., & Heymann, D. (2007) · Oncology Reports · doi:10.3892/or.18.6.1365 · Cited by 81
Schwarz, R. E., Vujanović, N. L., & Hiserodt, J. C. (1989) · PubMed · Cited by 79
Blanco, S., Sanz-García, M., Santos, C. R., & Lazo, P. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001660 · Cited by 74
Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
El-Osta, H. E., Jankú, F., & Kurzrock, R. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0156 · Cited by 74
Role of cyclooxygenase‐2 and inducible nitric oxide synthase in pancreatic cancer
Kong, G., Kim, E. K., Kim, W. S., Lee, K. T., Lee, Y. W., Lee, J. K., Paik, S. W., & Rhee, P. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02829.x · Cited by 73
Stock, A. T., Booth, S., & Cerundolo, V. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101967 · Cited by 71
Gehrmann, M., Schmetzer, H. M., Eißner, G., Haferlach, T., Hiddemann, W., & Multhoff, G. (2003) · PubMed · Cited by 71
Self-citationPaepe, B. D., Verstraeten, V. L. R. M., Potter, C. R. D., & Bullock, G. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0356-0 · Cited by 69
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL–6 trans-signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H., Wirtz, S. J., Becker, A., Burg, J., Strand, S., Kießlich, R., Huber, S., et al. (2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-831593 · Cited by 67
Berger, F. G. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0726-0 · Cited by 66
Tjiu, J., Liao, Y., Lin, S., Huang, Y., Tsai, W.-L., Chu, C., Kuo, M., & Jee, S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700191 · Cited by 65
O'Neill, L. A. J. (2000) · Science s STKE · doi:10.1126/stke.2000.44.re1 · Cited by 65
Neckers, L., & Lee, Y. S. (2003) · Nature · doi:10.1038/425357a · Cited by 64
Molecular chaperones in mammary cancer growth and breast tumor therapy
Calderwood, S. K., & Gong, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23461 · Cited by 64
Cited by
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713
Yang, Y., Wu, C., Hsu, P., Chen, S., Huang, S., Chan, W. L., Lin, S., Chou, C., Chen, J., Pan, J., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13230 · Cited by 692
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics
Chamoli, A., Gosavi, A. S., Shirwadkar, U. P., Wangdale, K. V., Behera, S. K., Kurrey, N. K., Kalia, K., & Mandoli, A. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105451 · Cited by 589
Metadata
- Authors
- Multhoff, G., Molls, M., & Radons, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 2
- Pages
- 98-98
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W1984752955
- Cited by
- 576
- References
- 240
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.